Lansoprazole Capsule, Delayed Release
Product Images NDC 45802-878

1 FDA label image from Padagis Israel Pharmaceuticals Ltd · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 45802-878). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazole Delayed Release Capsules Image (Image 01)

Lansoprazole Delayed Release Capsules Image (Image 01)
Lansoprazole Delayed-Release Capsules, 15 mg, oral acid reducer by Perrigo distributed by Padagis Israel Pharmaceuticals Ltd. The label indicates 14 capsules per bottle for a one 14-day course of treatment, sodium-free, and includes warnings, directions for use, and other drug facts. The packaging also shows an image of the capsule and the bottle.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.